Time-to-treatment and infarct size in STEMI patients undergoing primary angioplasty

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1508-1513

  De Luca, Giuseppe ^a   Parodi, Guido ^b   Sciagrà, Roberto ^b   Venditti, Francesco ^b   Bellandi, Benedetta ^b   Vergara, Ruben ^b   Migliorini, Angela ^b   Valenti, Renato ^b   Antoniucci, David ^b  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Infarct size; Primary angioplasty; Time to treatment

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGE; ARTICLE; CARDIOVASCULAR PARAMETERS; CORONARY STENT; DYSLIPIDEMIA; HEART INFARCTION SIZE; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOLYSIS IN MYOCARDIAL INFARCTION CORONARY FLOW; TIME TO TREATMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

INFARCT SIZE; PRIMARY ANGIOPLASTY; TIME-TO-TREATMENT;

AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TIME-TO-TREATMENT;

EID: 84881479967     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.078     Document Type: Article

References (48)

1. G. De Luca, E. Cassetti, and P. Marino Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction Am J Emerg Med 27 2009 712 719
2. G. De Luca, G. Biondi-Zoccai, and P. Marino Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials Ann Emerg Med 52 2008 665 676
3. G. Parodi, G. Memisha, and R. Valenti Five-year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience Heart 91 2005 1541 1544
4. E. Di Lorenzo, R. Sauro, and A. Varricchio Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial Am Heart J 158 4 2009 Oct e43 e50
5. G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
6. G. De Luca, E. Cassetti, M. Verdoia, and P. Marino Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analysis of randomised trials Thromb Haemost 102 2009 428 436
7. D. Antoniucci, A. Migliorini, and G. Parodi Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone Circulation 109 2004 1704 1706
8. G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
9. G. De Luca, G. Ucci, E. Cassetti, and P. Marino Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis J Am Coll Cardiol 53 2009 1668 1673
10. G. De Luca, C.M. Gibson, and F. Bellandi Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart 94 2008 1548 1558
11. G. De Luca, D. Dudek, G. Sardella, P. Marino, B. Chevalier, and F. Zijlstra Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials Eur Heart J 29 2008 3002 3010
12. G. De Luca, A.C. Maas, and H. Suryapranata Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction Am Heart J 150 2005 1248 1254
13. G. Parodi, R. Valenti, and N. Carrabba Long-term prognostic implications of non-optimal primary angioplasty for acute myocardial infarction Catheter Cardiovasc Interv 68 2006 50 55
14. L.K. Newby, W.R. Rutsch, and R.M. Califf Time from symptom onset to treatment and outcomes after thrombolyitc therapy J Am Coll Cardiol 27 1996 1646 1655
15. F. Zijlstra, C.L. Grines, and S. Ellis Clinical characteristics and outcome of patients with early (< 2 h), intermediate (2-4 h) and late (> 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction Eur Heart J 23 2002 550 557
16. B.R. Brodie, T.D. Stuckey, and T.C. Wall Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 32 1998 1312 1319
17. P.B. Berger, S.G. Ellis, and D.R. Holmes Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO IIb) trial Circulation 100 1999 14 20
18. C.P. Cannon, C.M. Gibson, and C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
19. D. Antoniucci, R. Valenti, and A. Migliorini Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty Am J Cardiol 89 2002 1248 1252
20. G. De Luca, H. Suryapranata, J.P. Ottervanger, and E.M. Antman Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225
21. G. De Luca, H. Suryapranata, and F. Zijlstra Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 42 2003 991 997
22. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings N Engl J Med 312 1985 932 936
23. R. Sciagrà, A. Imperiale, and D. Antoniucci Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention Eur J Nucl Med Mol Imaging 31 2004 969 974
24. M.K. O'Connor, T. Hammel, and R.J. Gibbons In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi) Eur J Nucl Med 17 1990 69 76
25. G. De Luca, A.W. van't Hof, and J.P. Ottervanger Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty Eur Heart J 26 2005 662 666
26. G. De Luca, C.M. Gibson, and F. Bellandi Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors Atherosclerosis 207 2009 181 185
27. A. Schömig, G. Ndrepepa, and J. Mehilli Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis Circulation 108 2003 1084 1088
28. G. Ndrepepa, A. Kastrati, and M. Schwaiger Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction J Nucl Med 46 2005 1782 1788
29. G. De Luca, N. Ernst, and F. Zijlstra Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 43 2004 1363 1367
30. G. De Luca, N. Ernst, and A.W. van't Hof Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty Am Heart J 150 2005 827 831
31. M. Leoncini, F. Bellandi, and R. Sciagrà Use of 99mTc-sestamibi gated SPECT to assess the influence of anterograde flow before primary coronary angioplasty on tissue salvage and functional recovery in acute myocardial infarction Eur J Nucl Med Mol Imaging 31 2004 1378 1385
32. G. De Luca, N. Ernst, and H. Suryapranata Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty Am J Cardiol 95 2005 1361 1363
33. M. Maeng, P.H. Nielsen, and M. Busk DANAMI-2 Investigators. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction - a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy Am J Cardiol 105 2010 1528 1534
34. E. Boersma The primary coronary angioplasty vs thrombolysis group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients Eur Heart J 27 2006 779 788
35. G. De Luca, A.W. van't Hof, and M.J. de Boer Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur Heart J 25 2004 1009 1013
36. B.R. Brodie, J. Webb, and D.A. Cox Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial) Am J Cardiol 99 2007 1680 1686
37. G.W. Stone, S.R. Dixon, and C.L. Grines Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials Am J Cardiol 100 2007 1370 1375
38. G. Tarantini, L. Cacciavillani, and F. Corbetti Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance J Am Coll Cardiol 46 2005 1229 1235
39. C.J. Terkelsen, J.T. Sørensen, and M. Maeng System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention JAMA 304 2010 763 771
40. C.J. Terkelsen, L.O. Jensen, and H.H. Tilsted Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data Ann Intern Med 155 2011 361 367
41. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial Lancet 367 2006 569 578
42. G. De Luca, and P. Marino Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials Am J Emerg Med 27 6 2009 Jul 683 690
43. G. De Luca, F. Bellandi, and K. Huber Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis J Thromb Haemost 9 12 Dec 2011 2361 2370
44. A.W. Van't Hof, J. Ten Berg, and T. Heestermans Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 9638 Aug 16 2008 537 546
45. G. De Luca Glycoprotein IIb-IIIa inhibitors Cardiovasc Ther 30 5 Oct 2012 e242 e254
46. S.G. Ellis, M. Tendera, and M.A. de Belder Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 21 2008 May 22 2205 2217
47. 99mTc- sestamibi defect size Circulation 88 1993 2224 2234
48. A. Migliorini, A. Stabile, and A.E. Rodriguez Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial J Am Coll Cardiol 56 2010 1298 1306